Literature DB >> 24112665

Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation.

Brandon C Chapman1, Ernest E Moore, Carlton Barnett, Robert T Stovall, Walter L Biffl, Clay C Burlew, Denis D Bensard, Gregory J Jurkovich, Fredric M Pieracci.   

Abstract

BACKGROUND: The optimal time to initiate venous thromboembolism pharmacoprophylaxis after blunt abdominal solid organ injury is unknown.
METHODS: Postinjury coagulation status was characterized using thromboelastography (TEG) in trauma patients with blunt abdominal solid organ injuries; TEG was divided into 12-hour intervals up to 72 hours.
RESULTS: Forty-two of 304 patients (13.8%) identified underwent multiple postinjury thromboelastographic studies. Age (P = .45), gender (P = .45), and solid organ injury grade (P = .71) were similar between TEG and non-TEG patients. TEG patients had higher Injury Severity Scores compared with non-TEG patients (33.2 vs 18.3, respectively, P < .01). Among the TEG patients, the shear elastic modulus strength and maximum amplitude values began in the normal range within the first 12-hour interval after injury, increased linearly, and crossed into the hypercoagulable range at 48 hours (15.1 ± 1.9 Kd/cs and 57.6 ± 1.6 mm, respectively; P < .01, analysis of variance).
CONCLUSIONS: Patients sustaining blunt abdominal solid organ injuries transition to a hypercoagulable state approximately 48 hours after injury. In the absence of contraindications, pharmacoprophylaxis should be considered before this time for effective venous thromboembolism prevention.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blunt solid organ injury; Hypercoagulable; Trauma

Mesh:

Year:  2013        PMID: 24112665      PMCID: PMC4091755          DOI: 10.1016/j.amjsurg.2013.07.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  25 in total

1.  Organ injury scaling: spleen and liver (1994 revision).

Authors:  E E Moore; T H Cogbill; G J Jurkovich; S R Shackford; M A Malangoni; H R Champion
Journal:  J Trauma       Date:  1995-03

2.  A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors:  W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

3.  Statewide, population-based, time-series analysis of the frequency and outcome of pulmonary embolus in 318,554 trauma patients.

Authors:  J E Tuttle-Newhall; R Rutledge; C S Hultman; S M Fakhry
Journal:  J Trauma       Date:  1997-01

4.  Organ injury scaling: spleen, liver, and kidney.

Authors:  E E Moore; S R Shackford; H L Pachter; J W McAninch; B D Browner; H R Champion; L M Flint; T A Gennarelli; M A Malangoni; M L Ramenofsky
Journal:  J Trauma       Date:  1989-12

5.  Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D.

Authors:  V G Nielsen; B T Geary; M S Baird
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

6.  Pulmonary embolism in major trauma patients.

Authors:  K F O'Malley; S E Ross
Journal:  J Trauma       Date:  1990-06

7.  Platelets are dominant contributors to hypercoagulability after injury.

Authors:  Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Anirban Banerjee; Christopher C Silliman; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2013-03       Impact factor: 3.313

8.  Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.

Authors:  M Margaret Knudson; Danagra G Ikossi; Linda Khaw; Diane Morabito; Larisa S Speetzen
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

9.  Thromboembolism following multiple trauma.

Authors:  M M Knudson; J A Collins; S B Goodman; D W McCrory
Journal:  J Trauma       Date:  1992-01

10.  Bleeding manifestations after early use of low-molecular-weight heparins in blunt splenic injuries.

Authors:  Kathia V Alejandro; José A Acosta; Pablo A Rodríguez
Journal:  Am Surg       Date:  2003-11       Impact factor: 0.688

View more
  14 in total

1.  When is It Safe to Start VTE Prophylaxis After Blunt Solid Organ Injury? A Prospective Study from a Level I Trauma Center.

Authors:  Morgan Schellenberg; Kenji Inaba; Subarna Biswas; Patrick Heindel; Elizabeth Benjamin; Aaron Strumwasser; Kazuhide Matsushima; Lydia Lam; Demetrios Demetriades
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

2.  Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?

Authors:  Joshua J Sumislawski; Lucy Z Kornblith; Amanda S Conroy; Rachael A Callcut; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2018-11       Impact factor: 3.313

Review 3.  Follow-up strategies for patients with splenic trauma managed non-operatively: the 2022 World Society of Emergency Surgery consensus document.

Authors:  Mauro Podda; Belinda De Simone; Marco Ceresoli; Francesco Virdis; Francesco Favi; Johannes Wiik Larsen; Federico Coccolini; Massimo Sartelli; Nikolaos Pararas; Solomon Gurmu Beka; Luigi Bonavina; Raffaele Bova; Adolfo Pisanu; Fikri Abu-Zidan; Zsolt Balogh; Osvaldo Chiara; Imtiaz Wani; Philip Stahel; Salomone Di Saverio; Thomas Scalea; Kjetil Soreide; Boris Sakakushev; Francesco Amico; Costanza Martino; Andreas Hecker; Nicola de'Angelis; Mircea Chirica; Joseph Galante; Andrew Kirkpatrick; Emmanouil Pikoulis; Yoram Kluger; Denis Bensard; Luca Ansaloni; Gustavo Fraga; Ian Civil; Giovanni Domenico Tebala; Isidoro Di Carlo; Yunfeng Cui; Raul Coimbra; Vanni Agnoletti; Ibrahima Sall; Edward Tan; Edoardo Picetti; Andrey Litvin; Dimitrios Damaskos; Kenji Inaba; Jeffrey Leung; Ronald Maier; Walt Biffl; Ari Leppaniemi; Ernest Moore; Kurinchi Gurusamy; Fausto Catena
Journal:  World J Emerg Surg       Date:  2022-10-12       Impact factor: 8.165

4.  It's sooner than you think: Blunt solid organ injury patients are already hypercoagulable upon hospital admission - Results of a bi-institutional, prospective study.

Authors:  Julia R Coleman; Annika B Kay; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Sarah Majercik; Mitchell J Cohen; Thomas White; Fredric M Pieracci
Journal:  Am J Surg       Date:  2019-09-10       Impact factor: 2.565

Review 5.  Global assays of hemostasis.

Authors:  Kathleen E Brummel-Ziedins; Alisa S Wolberg
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

6.  Targeting resuscitation to normalization of coagulating status: Hyper and hypocoagulability after severe injury are both associated with increased mortality.

Authors:  Hunter B Moore; Ernest E Moore; Ioannis N Liras; Charles Wade; Benjamin R Huebner; Clay Cothren Burlew; Fredric M Pieracci; Angela Sauaia; Bryan A Cotton
Journal:  Am J Surg       Date:  2017-09-18       Impact factor: 2.565

7.  Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe.

Authors:  Patrick B Murphy; Niroshan Sothilingam; Tanya Charyk Stewart; Brandon Batey; Brad Moffat; Daryl K Gray; Neil G Parry; Kelly N Vogt
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

8.  Thromboelastography Detects Possible Coagulation Disturbance in Pediatric Patients with Portal Cavernoma.

Authors:  Linfeng Wu; Gaofu Zhang; Chunbao Guo
Journal:  Transfus Med Hemother       Date:  2019-07-03       Impact factor: 3.747

9.  The association of ABO blood groups and trauma outcomes: A retrospective analysis of 3779 patients.

Authors:  Michael W Sauder; Timothy W Wolff; Aimee K LaRiccia; M Chance Spalding; Urmil B Pandya
Journal:  Int J Crit Illn Inj Sci       Date:  2021-06-29

Review 10.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.